Andhra Medi Pharma India Private Limited, a active private limited company, was established on 26 November 2009 in Vijayawada, Andhra Pradesh, India. Engaging in organic chemicals & compounds within the manufacturing sector, it holds CIN: U24233AP2009PTC065969. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.25 Cr and a paid-up capital of ₹2.25 Cr.
It upholds a compliant status. Employing 89 professional, Its leadership includes Kolathur Srinarayanan (Director), Burugupalli Srinivas (Director), Garikipati Kishore Kumar (Director). Past directors included Kolathur Srinarayanan, Burugupalli Srinivas. It holds ₹18.15 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No:40-25-35/1, Opp Kesava Towres, Ashram Street,Patamata Lanka, Vijayawada, Andhra Pradesh, 520010.
U24233AP2009PTC065969
065969
26 November 2009
₹2.25 Cr
₹2.25 Cr
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Andhra Medi Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kolathur Srinarayanan | Director | 03 Dec 2010 | Current |
| Burugupalli Srinivas | Director | 03 Dec 2010 | Current |
| Garikipati Kishore Kumar | Director | 15 Apr 2011 | Current |
| Anjana Chilakapati | Director | 26 Nov 2009 | Current |
| Sirigina Srinivasa Rao | Director | 15 Apr 2011 | Current |
| Rajeev Chilakapati | Director | 26 Nov 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2011 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Andhra Medi Pharma India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.17% decrease. The company also saw a substantial fall in profitability, with a 48.43% decrease in profit. The company's net worth moved up by a moderate rise of 9.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Andhra Medi Pharma India had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹181,539,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2022 | Indian Bank | ₹3.50 Cr | Open |
| 14 Jul 2022 | Indian Bank | ₹1.16 Cr | Open |
| 14 Jul 2020 | Indian Bank | ₹9.90 M | Open |
| 20 Apr 2011 | Indian Bank | ₹12.50 Cr | Open |
Explore comprehensive loan charge details -
Andhra Medi Pharma India has a workforce of 89 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Andhra Medi Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Andhra Medi Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Andhra Medi Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Andhra Medi Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
Progress on A charge with Indian Bank amounted to Rs. 3.50 Cr with Charge ID 100619399 was registered on 07 Sep 2022. was documented.
Progress on A charge with Indian Bank of Rs. 12.50 Cr registered on 20 Apr 2011 with Charge ID 10285586 was modified on 07 Sep 2022. was documented.
Progress on A charge with Indian Bank amounted to Rs. 1.16 Cr with Charge ID 100601092 was registered on 14 Jul 2022. was documented.
Progress on A charge with Indian Bank amounted to Rs. 0.99 Cr with Charge ID 100351599 was registered on 14 Jul 2020. was documented.
The CIN of Andhra Medi Pharma India Private Limited is U24233AP2009PTC065969.
Andhra Medi Pharma India Private Limited is headquartered at D.No:40-25-35/1, Opp Kesava Towres, Ashram Street,Patamata Lanka, Vijayawada, Andhra Pradesh, 520010.
Andhra Medi Pharma India Private Limited was incorporated on 26 November 2009.
The current directors of Andhra Medi Pharma India Private Limited are
The primary industry of Andhra Medi Pharma India Private Limited is Manufacturing.
Andhra Medi Pharma India Private Limited is unlisted.
The authorized capital of Andhra Medi Pharma India Private Limited is ₹2.25 Cr, and the paid-up capital is ₹2.25 Cr.
The compliance status of Andhra Medi Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX